Scholarly Index
Paolo Corradini
Fondazione IRCCS Istituto Nazionale dei Tumori; 27,718 total citations; 876 total publications; best world rank #91
Fondazione IRCCS Istituto Nazionale dei Tumori
27,718Total citations
876Total publications
86H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Multiple Myeloma Research and Treatments | Lifetime | 91 | IT 7 | 99.37 |
| Lymphoma Diagnosis and Treatment | Lifetime | 199 | IT 15 | 99.37 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 235 | IT 11 | 98.95 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 404 | IT 26 | 98.86 |
| CAR-T cell therapy research | Lifetime | 436 | IT 19 | 98.72 |
| T-cell and Retrovirus Studies | Lifetime | 195 | IT 5 | 97.79 |
| Viral-associated cancers and disorders | Lifetime | 358 | IT 21 | 97.98 |
| Protein Degradation and Inhibitors | Lifetime | 311 | IT 13 | 97.52 |
| COVID-19 and healthcare impacts | Lifetime | 869 | IT 100 | 92.30 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 369 | IT 27 | 95.72 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 551 | IT 52 | 95.25 |
| CAR-T cell therapy research | 2021-2025 | 156 | IT 6 | 98.86 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 140 | IT 8 | 98.52 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 389 | IT 26 | 96.01 |
| Neutropenia and Cancer Infections | 2021-2025 | 650 | IT 48 | 73.62 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 931 | IT 50 | 73.07 |
| T-cell and Retrovirus Studies | 2021-2025 | 513 | IT 18 | 70.90 |